Related Experiment Video
Updated: Feb 3, 2026

Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches
Published on: April 20, 2021
Nuclear FOXO1 promotes lymphomagenesis in germinal center B cells
Eleni Kabrani1, Van Trung Chu1,2, Evangelia Tasouri3
1Immune Regulation and Cancer, Max Delbrück Center for Molecular Medicine in the Helmholtz Alliance, Berlin-Buch, Germany.
Abstract:
Forkhead box class O1 (FOXO1) acts as a tumor suppressor in solid tumors. The oncogenic phosphoinositide-3-kinase (PI3K) pathway suppresses FOXO1 transcriptional activity by enforcing its nuclear exclusion upon AKT-mediated phosphorylation. We show here abundant nuclear expression of FOXO1 in Burkitt lymphoma (BL), a germinal center (GC) B-cell-derived lymphoma whose pathogenesis is linked to PI3K activation. Recurrent FOXO1 mutations, which prevent AKT targeting and lock the transcription factor in the nucleus, are used by BL to circumvent mutual exclusivity between PI3K and FOXO1 activation. Using genome editing in human and mouse lymphomas in which MYC and PI3K cooperate synergistically in tumor development, we demonstrate proproliferative and antiapoptotic activity of FOXO1 in BL and identify its nuclear localization as an oncogenic event in GC B-cell-derived lymphomagenesis.
Insights
Forkhead box class O1 (FOXO1) is typically a tumor suppressor. However, in Burkitt lymphoma, FOXO1 mutations promote cancer by enabling its nuclear localization, driving proliferation and preventing cell death.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Forkhead box class O1 (FOXO1) functions as a tumor suppressor in solid tumors.
- The phosphoinositide-3-kinase (PI3K) pathway inhibits FOXO1 activity by promoting its nuclear exclusion via AKT-mediated phosphorylation.
Purpose of the Study:
- To investigate the role of FOXO1 in Burkitt lymphoma (BL), a germinal center (GC) B-cell lymphoma.
- To understand how BL circumvents the typical tumor-suppressive function of FOXO1 despite PI3K pathway activation.
Main Methods:
- Analysis of FOXO1 expression in BL samples.
- Identification and characterization of recurrent FOXO1 mutations in BL.
- Genome editing in human and mouse lymphoma models with MYC and PI3K cooperation.
- Assessment of FOXO1's functional impact on proliferation and apoptosis.
Main Results:
- Abundant nuclear expression of FOXO1 was observed in BL.
- Recurrent FOXO1 mutations were identified that prevent AKT-mediated phosphorylation, locking FOXO1 in the nucleus.
- These mutations allow BL to overcome the mutual exclusivity between PI3K and FOXO1 activation.
- FOXO1 nuclear localization demonstrated proproliferative and antiapoptotic effects in BL models.
Conclusions:
- FOXO1 nuclear localization is an oncogenic event in GC B-cell-derived lymphomagenesis, specifically in BL.
- Mutations in FOXO1 are a mechanism by which BL utilizes this transcription factor to promote lymphomagenesis.
Related Concept Videos
Nuclear Stability
To hold positively charged protons together...
The Eukaryotic Promoter Region
Nuclear Fusion
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
Non-nuclear Inheritance
Lattice Centering and Coordination Number
Types of Unit Cells
Imagine taking a large number of identical...
Nuclear Export of mRNA

